期刊文献+

熊果酸辅助吉西他滨降低胰腺癌细胞耐药性并增强抗肿瘤作用的实验研究

Ursolic acid as an adjuvant reduces drug resistance of pancreatic cancer cells and enhances its anti-tumor effect in gemcitabine chemotheray
原文传递
导出
摘要 目的:探讨熊果酸(UA)辅助吉西他滨(Gem)通过降低胰腺癌(PC)细胞耐药性增强抗肿瘤效果的药理机制。方法:将体外培养的人胰腺癌细胞株SW1990细胞分别加入磷酸盐缓冲液(PBS)、Gem、UA以及Gem加UA孵育4 h,用噻唑蓝比色法(MTT法)检测细胞增殖,实时定量聚合酶链反应(RT-q PCR)检测细胞中凋亡相关基因的变化;通过皮下注射SW1990细胞构建PC荷瘤小鼠模型,予荷瘤小鼠瘤内注射PBS、Gem5 mg·kg^-1、UA 2 mg·kg^-1及Gem加UA,分别用HE和TUNEL染色观察各组小鼠肿瘤组织病理学变化,并记录所有小鼠存活情况。结果:Gem与UA联合用药对SW1990细胞的杀伤效果大于单独使用Gem和UA杀死细胞之和,且与PBS组比较,Gem联合UA可以显著下调细胞中抗凋亡基因Bcl-2的mRNA表达水平(P<0.05),上调促凋亡基因Bax和Caspase-3的mRNA表达水平(P<0.05);Gem明显提高荷瘤小鼠肿瘤细胞中P-gp蛋白的表达水平(P<0.01);病理学观察结果显示,Gem与UA联合用药后肿瘤组织坏死及细胞凋亡明显,促凋亡作用大于单纯使用Gem与UA之和,最终荷瘤小鼠存活率最高。结论:UA可作为佐剂有效逆转PC对Gem化疗的多药耐药,增强化疗效果,提高荷瘤小鼠存活率。 Objective: To investigate the pharmacological mechanism of gemcitabine(Gem) combined with ursolic acid(UA) for enhancing anti-tumor effect by reducing drug resistance of pancreatic cancer(PC) cells.Methods:SW1990 cells cultured in vitro were incubated with PBS,Gem,UA and Gem + UA for 4 hours,and thereafter the cell proliferation was detected by MTT assay.Real-time quantitative polymerase chain reaction(RT-qPCR) was used to detect the changes of apoptosis-related genes.PC tumor-bearing mouse model was constructed by subcutaneous injection of SW1990 cells,then PBS,Gem 5 mg · kg-1,UA 2 mg·kg-1 and Gem + UA were injected into tumor-bearing mice.The histopathological changes of tumors in each group were detected by HE and TUNEL staining respectively,and the survival rate of all mice were recorded.Results: The lethality of Gem + UA to SW1990 cells was greater than the sum of free Gem and free UA.Compared with PBS group,Gem + UA significantly down-regulated the mRNA expression level of anti-apoptotic gene Bcl-2 in PC cells(P<0.05),and up-regulated the mRNA expression levels of pro-apoptotic genes Bax and Caspase-3(P<0.05).The results showed that Gem increased the protein expression levels of P-gp in tumor cells of the mice significantly(P<0.01).The pathological examination also showed that there were obvious necrosis and apoptosis in tumor tissue after the treatment with Gem + UA,and the pro-apoptotic effect was more potent than the sum of the Gem and UA group used alone.Of all the groups,the survival rate in Gem + UA group was the highest.Conclusion: UA can be used as an adjuvant to effectively reverse the multidrug resistance induced by Gem chemotherapy in PC,which can enhance the effect of chemotherapy and improve the survival rate of tumor-bearing mice.
作者 高峰 李凡 孙婷 邹鹏林 刘龙 金利芳 邵春娟 史秋生 杜联芳 GAO Feng;LI Fan;SUN Ting;ZOU Penglin;LIU Long;JIN Lifang;SHAO Chunjuan;SHI Qiusheng;DU Lianfang(Department of Ultrasound,Shanghai General Hospital,Shanghai Jiaotong University School of Medicine,Shanghai 200080,China)
出处 《现代医学》 2019年第10期1181-1187,共7页 Modern Medical Journal
基金 国家自然科学基金资助项目(81771838)
关键词 胰腺癌 吉西他滨 熊果酸 耐药性 小鼠 pancreatic cancer gemcitabine ursolic acid multi-drug resistance mice
  • 相关文献

参考文献7

二级参考文献47

  • 1Chiara Tosolini,Christoph W Michalski,Jrg Kleeff.胰腺的癌症病人的反应评估追随者 neoadjuvant 治疗[J].World Journal of Gastrointestinal Surgery,2013,5(2):12-15. 被引量:7
  • 2Ru-FuChen,Zhi-HuaLi,Xian-HeKong,Ji-ShengChen.Effect of mutated IKBa transfection on multidrug resistance in hilar cholangiocarcinoma cell lines[J].World Journal of Gastroenterology,2005,11(5):726-728. 被引量:9
  • 3肖坤福,郑云法,刘成左,张春牛.熊果酸的研究进展[J].时珍国医国药,2005,16(12):1298-1300. 被引量:33
  • 4王丽,李辉.胰腺癌遗传流行病学研究进展[J].中国医学科学院学报,2006,28(2):289-293. 被引量:4
  • 5MEDINE E I’ONAK P’SAKARYA S,et al. Investigation of invitro efficiency of magnetic nanoparticle- conjugated 1251* ura-cil glucuronides in adenocarcinoma cells[ J]. J Nanopar Res,2011,13(10) :4703-4715.
  • 6HAFEU U,PAUER G,FAILING S,et al. Radiolabeling ofmagnetic particles with rhenium-188 for cancer therapy [ J ]. JMag Mag Mater,2001,225( 1 ) :73-78.
  • 7JORDAN A’SCHOLZ R’WUST P,et al. Magnetic fluid hyper-thermia (MFH) : cancer treatment with AC magnetic field in-duced excitation of biocompatible superparamagnetic nanopar-ticles[J]. J Mag Mag Mater, 1999,201 ( 1 ) :413-419.
  • 8EMILIAN LEUCUTA S. Nanotechnology for delivery of drugsand biomedical applications [ J ]. Curr Clin Pharmacol, 2010,5(4):257-280.
  • 9KRUKEMEYER M G,KRENN V, JAKOBS M,et al. Mitox-antrone- iron oxide biodistribution in blood,tumor,spleen,andliver- magnetic nanoparticles in cancer treatment [ J ]. J SurgRes,2012,175(1) :35-43.
  • 10杨秉辉,丛文铭,周晓军,陈孝平,杨甲梅,樊嘉,王建华,杨仁杰,李槐,蒋国梁,曾昭冲,陈敏华,陈敏山,梁萍,吕明德,罗荣城,刘鲁明,秦叔逵,叶胜龙,吴孟超,汤钊猷,孙燕,管忠震.原发性肝癌规范化诊治专家共识[J].临床肿瘤学杂志,2009,14(3):259-269. 被引量:310

共引文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部